dostarlimab-gxly


Background. Dostarlimab is an immune-checkpoint inhibitor that targets the programmed cell death 1 receptor. The combination of chemotherapy and immunotherapy may have synergistic effects in the.



Jemperli (dostarlimab) is a member of the anti-PD-1 monoclonal antibodies drug class and is commonly used for Endometrial Cancer, and Solid Tumors. The cost for Jemperli intravenous solution (gxly 500 mg/10 mL) is around $11,540 for a supply of 10 milliliters, depending on the pharmacy you visit.



(57 products available) View by: List | Grid || Supplier Location Near Me All India Jemperli 500mg Injection ₹ 7 Lakh/ Vial Get Latest Price Packaging Size: 10ml in 1 vial Brand: Jemperli 500mg Composition: Dostarlimab-gxiy Prescription/Non prescription: Non prescription Strength: 500mg read more. Brochure Amoha Impex Surat



MSK researchers conducted a prospective study in which single agent dostarlimab, an anti-PD-1 monoclonal antibody, was administered every three weeks for six months in patients with mismatch repair-deficient stage 2 and 3 rectal adenocarcinoma, to be followed by standard chemoradiation and surgery.